Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1990-5-2
|
pubmed:abstractText |
We have assessed the validity of using platelet-rich plasma (PRP) to measure dopamine uptake by platelets. In addition, we report on a pilot study comparing [3H]dopamine uptake by PRP from psychotic patients to that by PRP from healthy volunteers. Uptake of radiolabelled dopamine by PRP was related to the concentration of [3H]dopamine added and correlated with platelet number. [3H]dopamine uptake by PRP was not altered by varying pH (6.8 to 8.0) or by the time PRP was incubated prior to the addition of the radiolabelled dopamine. 11.7 +/- 0.34% (mean +/- SEM) of [3H]dopamine added to plasma was precipitated by polyethylene glycol (PEG) and appeared to be associated with a large molecular mass component of plasma. The amount of PEG precipitable [3H]dopamine did not correlate with dopamine uptake (r = 0.02) or differ between patients and controls. Uptake of [3H]dopamine by PRP from 52 volunteers (26 M, 26 F; age, 18-75 yr), expressed as the area under the dopamine uptake curve up to 60 min in arbitrary units, ranged from 72-285 for males and 59-455 for females. Comparing [3H]dopamine uptake by PRP from 15 psychotic patients to these sex-specific reference ranges 9 of 13 PRP from schizophrenic patients had [3H]dopamine uptake outside the normative values whereas the two non-schizophrenic patients did not differ from normal. Dopamine uptake by PRP may be useful in the study of diseases with altered dopaminergic activity in the CNS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0009-8981
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
31
|
pubmed:volume |
187
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
37-46
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2317927-Adolescent,
pubmed-meshheading:2317927-Adult,
pubmed-meshheading:2317927-Aged,
pubmed-meshheading:2317927-Blood Platelets,
pubmed-meshheading:2317927-Depressive Disorder,
pubmed-meshheading:2317927-Dopamine,
pubmed-meshheading:2317927-Evaluation Studies as Topic,
pubmed-meshheading:2317927-Female,
pubmed-meshheading:2317927-Humans,
pubmed-meshheading:2317927-Hydrogen-Ion Concentration,
pubmed-meshheading:2317927-Male,
pubmed-meshheading:2317927-Middle Aged,
pubmed-meshheading:2317927-Pilot Projects,
pubmed-meshheading:2317927-Platelet Count,
pubmed-meshheading:2317927-Reference Values,
pubmed-meshheading:2317927-Schizophrenia,
pubmed-meshheading:2317927-Time Factors
|
pubmed:year |
1990
|
pubmed:articleTitle |
Validation of a method to measure the uptake of [3H]dopamine by human platelets.
|
pubmed:affiliation |
Mental Health Research Institute of Victoria, Parkville, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|